Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,930,764
-$5,971,935 QoQ
Shares Held
28,552
-39.3% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026EVENTIDE ASSET MANAGEMENT, LLC holds $107,290,135 across 5 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,424,282 | $47,101,005 | |
| 2 | ADCT |
ADC Therapeutics SA
|
5,701,655 | $21,381,206 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,513,958 | $21,044,016 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
28,552 | $16,930,764 | |
| 5 | ZTS |
Zoetis Inc.
|
7,048 | $833,144 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,930,764 | 28,552 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,902,699 | 47,004 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,092,049 | 62,241 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,574,701 | 47,241 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,562,983 | 47,241 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,931,373 | 67,825 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,305,088 | 67,825 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,605,653 | 67,825 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||